Annual Pharma Pricing, Reimbursement & Market Access Conference

Annual Pharma Pricing, Reimbursement & Market Access will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will focus on themes such as Preparing your best market access strategy, EU and US policy challenges for market access: Stepping ahead, Unrivalled opportunity to expose and address the market access challenges facing the industry, Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access, etc.

Spotlight


OTHER PAST CONFERENCES

SmartLab Exchange Europe 2024

February 21-22, 2024 | Netherlands

The SmartLab Exchange brings together a select group of leading experts from across the smart laboratory space for innovative learning and thought-leadership discussions. This group of R&D/R&D IT, Manufacturing, and QA/QC experts will deliver a number of insightful sessions through inspiring keynotes, in-depth case studies and fireside chats, interactive panels, and intimate roundtables across two-days. In between the exclusive content sessions you will have limitless networking opportunities during peer-to-peer networking and coffee breaks in addition to two drinks receptions. Alongside this our consultative one-to-one business meetings between attendees and solution providers will be carefully scheduled throughout the two-days to meet your specific business needs.

2024 ISPE Aseptic Conference

March 12-13, 2024 | Austria

In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before. Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address. Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems. In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!

International Conference on Pharmacy and Pharmaceutical Science (ICPPS-24)

March 11-12, 2024 | Spain

The International Conference on Pharmacy and Pharmaceutical Science ICPPS. It will be held on 11th - 12th-Mar-2024 at Madrid, Spain. ICPPS and is being organized by ITAR-India to provide an opportunity to research scholars, delegates and students to interact and share their experience and knowledge in technology application.

Pharma Contract Manufacturing Conference Europe

April 9-11, 2024 | Germany

Welcome To The Industry’s Leading Pharma Contract Manufacturing Event. Pharma Contract Manufacturing is the only event to focus specifically on how to improve CMO selection and partnering. We appreciate the critical role these play in delivering success for both patients and the organisation-at-large. We also appreciate that the bedrock of these relationships is collaboration from both sides, which is why we bring together leading pharmaceutical companies and CMOs to benchmark best practice in this area. Selecting the right CMO partner is the critical decision in getting high-quality products to patients. If this relationship fails, we fail. Our companies and patients can’t afford for us to get this decision wrong. That’s why Pharma IQ is bringing together partners from across the industry to collaborate on how we make these relationships work both now and in the future. Because for the patient to succeed, we need to succeed.